The enkephalinase inhibitor thiorphan shows antinociceptive activity in mice
Authors:
- B. P. RoquesBRB. P. Roques
- M. C. Fournié-ZaluskiMFM. C. Fournié-Zaluski
- E. SorocaESE. Soroca
- J. M. LecomteJLJ. M. Lecomte
- B. MalfroyBMB. Malfroy
- C. LlorensCLC. Llorens
- J.-C. SchwartzJSJ.-C. Schwartz
- 1 November 1980
- journal article
- research article
- Published by Springer Nature in Nature
- Vol. 288 (5788) , 286-288
Abstract
There is both theoretical and therapeutic interest in establishing whether the signals conveyed by the enkephalins are turned off under the action of a specific peptidase which might, in this case, represent a target for a new class of psychoactive agents. Enkephalinase, a dipeptidyl carboxypeptidase cleaving the Gly3-Phe4 bond of enkephalins and distinct fropm angiotensin coverting enzyme (ACE), might be selectively involved in enkephalinergic transmission. It is a membrane-bound enzyme whose localization in the vicinity of opiate receptors in the central nervous system is suggested by parallel regional and subcellular distributions as well as by the effects of lesions. Such a role is further supported by the ontogenetic development of enkephalinase, its substrate specificity accounting for the increased biological activity of several enkephalin analogues and its adaptive increase following chronic treatment with morphine. To investigate the functional role of this enzyme further, we have designed a potent and specific enkephalinase inhibitor. We report here that this compound, thiorphan [(DL-3-mercapto-2-benzylpropanoyl)-glycine; patent no. 8008601] protects the enkephalins from the action of enkephalinase in vitro in nanomolar concentration and in vivo after either intracerebroventricular or systemic administration. In addition, thiorphan itself displays antinociceptive activity which is blocked by naloxone, an antagonist of opiate receptors.Keywords
This publication has 30 references indexed in Scilit:
- Ontogenesis of enkephalinergic systems in rat brain: Post-natal changes in enkephalin levels, receptors and degrading enzyme activitiesLife Sciences, 1980
- ENKEPHALINASE: PRELIMINARY CHARACTERIZATION AND COMPARISON WITH ANGIOTENSIN CONVERTING ENZYME1980
- DEGRADATION OF ENKEPHALIN BY TWO BRAIN ENZYMATIC ACTIVITIES1980
- ONTOGENESIS OF ENKEPHALINERGIC SYSTEMS IN RAT BRAIN1980
- Two distinct enkephalinases: Solubilization, partial purification and separation from angiotensin converting enzymeLife Sciences, 1979
- Enkephalin degradation in mouse brain studied by a new H.P.L.C. method: Further evidence for the involvement of carboxydipeptidaseLife Sciences, 1979
- ‘Enkephalinase’ is distinct from brain ‘angiostensin-converting enzyme’European Journal of Pharmacology, 1979
- Regional distribution of a high-affinity enkephalin-degrading peptidase (‘enkephalinase’) and effects of lesions suggest localization in the vicinity of opiate receptors in brainNeuroscience Letters, 1979
- Is ‘enkephalinase” identical with ‘angiotensin-converting enzyme’?European Journal of Pharmacology, 1979
- High-affinity enkephalin-degrading peptidase in brain is increased after morphineNature, 1978